News
Volastra Therapeutics today announced the dosing of the first patient in a Phase I/II clinical trial evaluating VLS-1488.
- Elumina is a Phase 2, multicenter, double-blind, randomized, placebo-controlled, clinical trial to assess the efficacy, safety and tolerability of VLS-01 (buccal film DMT) in people suffering ...
--atai Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced the completion of the Phase 1 study of VLS-01 in healthy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback